| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 07/11/2002 | WO2002054072A2 Assay to determine efficacy of treatment for mycobacterial infection |
| 07/11/2002 | WO2002054065A2 Reversible mhc multimer staining for functional purification of antigen-specific t cells |
| 07/11/2002 | WO2002053606A1 A new linker based solid support for peptide and small molecule organic synthesis |
| 07/11/2002 | WO2002053584A1 Stabilized pharmaceutical composition in lyophilized form |
| 07/11/2002 | WO2002053583A2 Amphipathic peptides and their use for transferring substances of interest into cells |
| 07/11/2002 | WO2002053182A1 Chimeric t helper-b cell peptide vaccine for japanese encephalitis virus |
| 07/11/2002 | WO2002053173A2 Design and use of advanced zinc chelating peptides to regulate matrix metalloproteinases |
| 07/11/2002 | WO2002053172A2 Use of matrix metalloproteinase peptide substrate to lower the rate of extracellular matrix turnover |
| 07/11/2002 | WO2002027315A3 Compounds with a branched linker |
| 07/11/2002 | WO2002020724A3 Adenoviral targeting and manipulation of immune system response using targeting peptides |
| 07/11/2002 | WO2001068145A3 Peptidase-cleavable, targeted antineoplastic drugs and their therapeutic use |
| 07/11/2002 | WO2001053331A3 Peptidomimetic modulators of cell adhesion |
| 07/11/2002 | WO2001018032A3 Dolastatin peptides |
| 07/11/2002 | WO2000075173A3 Peptide fragments of colostrinin |
| 07/11/2002 | US20020091234 Adjuvant for enhancing immune response to preferential immunogen |
| 07/11/2002 | US20020090671 Bone stimulating factor |
| 07/11/2002 | US20020090655 Analyzing dense core vessicles from brain tissues; obtain brain cells, incubate with extraction buffer, monitor vessicle tissues |
| 07/11/2002 | US20020090632 Measuring the concentration of preferential analyte in sample; obtain samples, incubate with binding particles, determine concentration of detectable particles |
| 07/11/2002 | US20020090609 Diagnostics and therapy of diseases associated with HHV-8 infections |
| 07/11/2002 | US20020090368 Therapeutic uses of bactericidal/permeability increasing (BPI) protein products |
| 07/11/2002 | CA2467434A1 Reversible mhc multimer staining for functional purification of antigen-specific t cells |
| 07/11/2002 | CA2433606A1 Amphipathic peptides and their use for transferring substances of interest into cells |
| 07/11/2002 | CA2433263A1 Stabilized pharmaceutical composition in lyophilized form |
| 07/11/2002 | CA2433236A1 Assay to determine efficacy of treatment for m. tuberculosis infection |
| 07/11/2002 | CA2431853A1 Design and use of advanced zinc chelating peptides to regulate matrix metalloproteinases |
| 07/10/2002 | EP1221484A2 Biosynthetic osteogenic proteins and osteogenic devices containing them |
| 07/10/2002 | EP1220902A2 Conjugates between a peptide and a nucleic acid analog, such as a pna, lna or a morpholino |
| 07/10/2002 | EP1220872A1 Uroguanylin as an intestinal cancer inhibiting agent |
| 07/10/2002 | EP1220871A2 Substituted phosphinate based peptide derivatives |
| 07/10/2002 | EP1220870A1 Metal-binding compounds and uses therefor |
| 07/10/2002 | EP1073451B1 Deltorphine for treating ischemia |
| 07/10/2002 | EP0820312B1 Ternary radiopharmaceutical complexes |
| 07/10/2002 | CN1358198A Chimeric polypeptides, method for production and uses thereof |
| 07/10/2002 | CN1358195A Inhibitors of integrin alpha V beta 6 |
| 07/10/2002 | CN1087283C New LH-RH antigonists with improved effectiveness |
| 07/10/2002 | CN1087175C Vaccines raising immunological response against viruses causing porcing respiratory and reproductive diseases |
| 07/09/2002 | US6417334 Antagonists to chaperonin 10 |
| 07/09/2002 | US6417327 Peptide capable of regulating physiological function of FGF-5 and pharmaceutical composition containing the peptide |
| 07/09/2002 | US6417326 Fusogenic liposomes |
| 07/09/2002 | US6417325 Administering cyclic peptide |
| 07/09/2002 | US6417324 Synthetic peptides that bind to the hepatitis B virus core and e antigens |
| 07/09/2002 | US6417163 Compositions and methods for controlling plant pests |
| 07/09/2002 | US6417010 Methods and apparatus for synthesizing labeled combinatorial chemistry libraries |
| 07/09/2002 | US6417009 Reservoir components |
| 07/09/2002 | US6416952 Photolithographic and other means for manufacturing arrays |
| 07/09/2002 | US6416949 Composition comprising first solid support linked to peptide covalently attached via linking group to second solid support linked to oligonucleotide, wherein supports are beads covalently attached by heterobifunctional crosslinking agent |
| 07/09/2002 | CA2042236C Seroreactive epitopes on proteins of human papillomavirus (hpv) 18 |
| 07/04/2002 | WO2002052262A1 Method and kit for screening substrate of abc protein |
| 07/04/2002 | WO2002051862A2 Cytostatic-glycoconjugates having specifically cleavable peptidiclinking units |
| 07/04/2002 | WO2002051861A2 Process for the synthesis of a peptide having a tryptophan residue |
| 07/04/2002 | WO2002051444A1 Conjugates of integrin receptor antagonists and a cytostatic agent having specifically cleavable linking units |
| 07/04/2002 | WO2001040265A3 Ligands for a target molecule and a method for indentifying them |
| 07/04/2002 | WO2000069900A9 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
| 07/04/2002 | WO2000069891A9 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins |
| 07/04/2002 | US20020086978 Specific binding agents |
| 07/04/2002 | US20020086008 Human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases |
| 07/04/2002 | US20020085997 Tumor cells at least some of which contain at least one MHC-I-haplotype of the patient on the cell surface, and which are charged with one or more peptides binding to the MHC-I molecule |
| 07/04/2002 | CA2433116A1 Conjugates of integrin receptor antagonists and a cytostatic agent having specifically cleavable linking units |
| 07/03/2002 | EP1219659A1 Amphipathic compound having dendritic structure |
| 07/03/2002 | EP1219634A1 Cytostatic-glycoconjugates having specifically cleavable peptidic linking units |
| 07/03/2002 | EP1219305A1 Conjugates of integrin receptor antagonists and a cytostatic agent having specifically cleavable linking units |
| 07/03/2002 | EP1218403A2 Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery |
| 07/03/2002 | EP1012174A4 Nik proteins, nucleic acids and methods |
| 07/03/2002 | EP0938326A4 Synthetic phosphopeptides for treating bone diseases |
| 07/03/2002 | CN1357006A Mage-A1 peptides presented by HLA class II molecules |
| 07/03/2002 | CN1357005A Process for partitioning of proteins |
| 07/03/2002 | CN1357000A Water soluble prodrugs of hindered alcohols or phenols |
| 07/02/2002 | US6414113 Amino acid sequence of peptide; for purifying and detecting bone marrow stromal cell antigen-1 |
| 07/02/2002 | US6414112 Peptide nucleic acids having 2,6-diaminopurine nucleobases |
| 07/02/2002 | US6413935 Oligopeptide |
| 07/02/2002 | US6413530 Pesticidal peptides |
| 07/02/2002 | US6413517 Identification of broadly reactive DR restricted epitopes |
| 07/02/2002 | CA2167678C Radioactive peptides |
| 07/02/2002 | CA2047792C Synthetic peptides specific for the detection of antibodies to hcv, diagnosis of hcv infection and prevention thereof as vaccines |
| 07/02/2002 | CA2032527C Lytic peptides: their use in the treatment of microbial infections, cancer and in the promotion of growth |
| 06/27/2002 | WO2002050250A2 Signal-1/signal-2 bifunctional peptide inhibitors |
| 06/27/2002 | WO2002050102A2 Inhibitors of the e2f-1/cyclin interaction for cancer therapy |
| 06/27/2002 | WO2002049577A2 Analogues of thiocoraline and be-22179 |
| 06/27/2002 | WO2002020822A3 Biopanning and rapid analysis of selective interactive ligands (brasil) |
| 06/27/2002 | WO2001081426A3 Rgd (arg-gly-asp) coupled to (neuro)peptides |
| 06/27/2002 | WO2001074849A3 Binding peptides for carcinoembryonic antigen (cea) |
| 06/27/2002 | WO2000056345A9 Methods for limiting scar and adhesion formation |
| 06/27/2002 | US20020082395 Immunoglobulin for use in diagnosis, treatment and prevention of bacterial infections |
| 06/27/2002 | US20020082219 Dendroaspis(green mamba snake) natriuretic peptide has at least one activity selected from the group consisting of vasodilation, antriuresis, diuresis and renin-suppressing activity |
| 06/27/2002 | US20020082217 Synthetic compounds, antibodies that recognize and bind to these compounds, polynucleotides that encode these compounds, and immune effector cells raised in response to presentation of these epitopes |
| 06/27/2002 | US20020082195 Novispirins: antimicrobial peptides |
| 06/27/2002 | US20020081690 Hybrid enzyme and use thereof |
| 06/27/2002 | US20020081595 Nucleotide sequences coding preferential polypeptide for use in humantherapeutics and diagnostics |
| 06/27/2002 | CA2432767A1 Signal-1/signal-2 bifunctional peptide inhibitors |
| 06/27/2002 | CA2432031A1 Inhibitors of the e2f-1/cyclin interaction for cancer therapy |
| 06/27/2002 | CA2430782A1 Analogues of thiocoraline and be-22179 |
| 06/26/2002 | EP1217005A1 Synthetic peptide having antitumor cytotoxic activity |
| 06/26/2002 | EP1216040A1 Agents for reducing cholesterol-uptake and lipid-uptake |
| 06/26/2002 | EP0464147B1 Matrix metalloproteinase inhibitor peptides |
| 06/26/2002 | CN1355813A Peptide having preptin functionality |
| 06/26/2002 | CN1355812A Pseudomycin analogs |
| 06/26/2002 | CN1355713A Releasable bond and composition containing said bond |
| 06/26/2002 | CN1355173A Liquid-phase synthesis process of octreotide acetate |
| 06/25/2002 | US6410696 Cyclosporin immunoassay |
| 06/25/2002 | US6410296 Herpes virus proteinase and method of assaying |